News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acutus Medical Charts $21 Million of a Hoped-for $31 Million Series B Round


6/14/2013 8:20:22 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Acutus Medical raises $nearly $21 million on its way to a hoped-for $31 million Series B round for its heart mapping device. Acutus Medical, fresh off a successful first-in-human trial of its heart-mapping technology, raised $21.6 million of a hoped-for $30.6 million Series B round, founder, president & CEO Randy Werneth told MassDevice.com today. San Diego-based Acutus developed a 3D cardiac electrical mapping system to identify areas of the heart muscle requiring ablation to treat atrial fibrillation. The system can deliver CT- or MRI-quality images of the heart's electrical activity, the company claims. Last year Acutus raised $5.4 million to fund the initial trial, Werneth told us.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES